Hepatitis B virus reactivation associated with ruxolitinib

Ann Hematol. 2014 Jun;93(6):1075-6. doi: 10.1007/s00277-013-1936-5. Epub 2013 Oct 31.

Authors

Chien-Heng Shen¹, Cih-En Hwang, Yi-Yang Chen, Chih-Cheng Chen

Affiliation

¹ Division of Gastroenterology, Department of Medicine, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan, Republic of China.

PMID: 24173089
DOI: 10.1007/s00277-013-1936-5

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antiviral Agents / therapeutic use
Enzyme Inhibitors / adverse effects*
Enzyme Inhibitors / therapeutic use
Guanine / analogs & derivatives
Guanine / therapeutic use
Hepatitis B virus / drug effects*
Hepatitis B virus / physiology
Hepatitis B, Chronic / complications
Hepatitis B, Chronic / drug therapy
Hepatitis B, Chronic / virology*
Humans
Immunocompromised Host
Janus Kinases / antagonists & inhibitors
Male
Nitriles
Primary Myelofibrosis / complications
Primary Myelofibrosis / drug therapy*
Pyrazoles / adverse effects*
Pyrazoles / therapeutic use
Pyrimidines
Thrombocythemia, Essential / complications
Virus Activation / drug effects*

Substances

Antiviral Agents
Enzyme Inhibitors
Nitriles
Pyrazoles
Pyrimidines
entecavir
Guanine
ruxolitinib
Janus Kinases